Skip to main content

Table 1 Clinical-biological features and in vitro fertilisation procedure outcomes of study women

From: High androgen concentrations in follicular fluid of polycystic ovary syndrome women

  Controls ECHO PCOS BMI Effect Condition Effect
  NW Obese NW Obese NW Obese   
BMI (kg/m2) 21.2 ± 2.0
(n= 26)
31.5 ± 4.1#
(n = 21)
21.6 ± 1.89
(n = 15)
29.4 ± 3.0
(n = 14)
21.05 ± 1.8
(n = 13)
34.06 ± 2.3°
(n = 13)
p < 0.001 p < 0.05
Follicle Count (n) 16.3 ± 5.0
(n = 23)
11.1 ± 4.3
(n = 20)
35.1 ± 13.0
(n = 15)
33.9 ± 4.5
(n = 14)
39.1 ± 14.7
(n = 17)
33.0 ± 8.4
(n = 7)
p< 0.05 p< 0.0001
Cycles Duration (d) 28.3 ± 2.8
(n = 42)
30.5 ± 1.8
(n = 28)
79.1 ± 62.7***/^^^
(n = 25)
NS p< 0.0001
Testosterone (μg/L) 0.40 ± 0.20
(n = 23)
0.35 ± 0.12
(n = 18)
0.61 ± 0.48^
(n = 25)
NS p< 0.05
AMH (ng/mL) 2.68 ± 1.74
(n = 47)
6.06 ± 2.38
(n = 29)
11.10 ± 11.66***/^^
(n = 30)
NS p< 0.0001
FSH (UI/L) 6.44 ± 2.33
(n = 46)
6.13 ± 1.97
(n = 29)
5.75 ± 1.77
(n = 29)
NS NS
LH (UI/L) 4.38 ± 1.65
(n = 46)
5.53 ± 2.65
(n = 28)
6.12 ± 2.96**
(n = 29)
NS p< 0.01
Oestradiol (ng/L) 46.87 ± 28.35
(n = 46)
41.56 ± 30.32
(n = 28)
37.03 ± 9.92
(n = 29)
NS NS
Matures Oocytes (n) 6.5 ± 3.5
(n = 46)
10.3 ± 6.1**
(n= 29)
8.3 ± 4.8
(n = 29)
NS p< 0.01
Embryos (n) 3.9 ± 3.0
(n = 46)
7.1 ± 4.4***
(n= 29)
5.4 ± 3.3
(n = 29)
NS p< 0.01
  1. Note: The values are expressed as mean ± standard deviation. ECHO women presenting ≥12 follicles per ovary without dysovulation and/or hyperandrogenism; PCOS Polycystic Ovary Syndrome; NW Normal-Weight; BMI Body Mass Index; AMH Anti-Müllerian Hormone; FSH Follicle-Stimulating Hormone; LH Luteinising Hormone
  2. #p < 0.05 versus obese ECHO; °p < 0.0001 versus obese ECHO; p < 0.0001 versus normal-weight Controls; p < 0.0001 versus obese Controls; * p < 0.05, ** p < 0.01, *** p < 0.001 versus Controls; ^ p < 0.05, ^^ p < 0.01, ^^^ p < 0.001 versus ECHO